No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reverse split coming?

copied and pasted from the 8-k

Discretionary Authority to Implement a Reverse Stock Split

 

The Majority Stockholders have approved an amendment to our Amended and Restated Articles of Incorporation (“Amendment”) (in the event it is deemed advisable by the Board) to effect a Reverse Stock Split of our issued and outstanding shares of Common Stock at a ratio to be determined in the discretion of our Board and publicly announced prior to the effectiveness of any Reverse Stock Split within the range of one (1) share of our Common Stock for every two (2) to four (4) shares of our Common Stock. The written consent vote, as of June 14, 2021, was:

 

Written Consent Vote Votes FOR Votes AGAINST Votes ABSTAIN
Totals: 6,422,290 0 0

 

 

Share
New Message
Please login to post a reply